Cited2 is required for the maintenance of glycolytic metabolism in adult hematopoietic stem cells

Stem Cells and Development

Volumn 23, Issue 2, 2014, Pages 83-94

  Du, Jinwei ^a   Li, Qiang ^a   Tang, Fangqiang ^a   Puchowitz, Michelle A ^b   Fujioka, Hisashi ^b   Dunwoodie, Sally L ^c,d   Danielpour, David ^a   Yang, Yu Chung ^a  

^a CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b CASE WESTERN RESERVE UNIVERSITY   (United States)

^c VICTOR CHANG CARDIAC RESEARCH INSTITUTE   (Australia)

^d UNIVERSITY OF NEW SOUTH WALES   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

CITED2 PROTEIN; GLUCOSE; GLUTATHIONE; LACTATE DEHYDROGENASE; MITOCHONDRIAL DNA; PEPTIDES AND PROTEINS; REACTIVE OXYGEN METABOLITE; UNCLASSIFIED DRUG; 2-(4-MORPHOLINYL)-8-PHENYL-4H-1-BENZOPYRAN-4-ONE; CHROMONE DERIVATIVE; CITED2 PROTEIN, MOUSE; D-LACTATE DEHYDROGENASE; ENZYME INHIBITOR; HIF1A PROTEIN, MOUSE; HYPOXIA INDUCIBLE FACTOR 1ALPHA; ISOENZYME; LACTATE DEHYDROGENASE 1; MECHANISTIC TARGET OF RAPAMYCIN COMPLEX 1; MORPHOLINE DERIVATIVE; MULTIPROTEIN COMPLEX; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B; PROTEIN SERINE THREONINE KINASE; PYRUVATE DEHYDROGENASE (ACETYL-TRANSFERRING) KINASE; REPRESSOR PROTEIN; TARGET OF RAPAMYCIN KINASE; TRANSACTIVATOR PROTEIN;

ANIMAL EXPERIMENT; APOPTOSIS; ARTICLE; CELL FUNCTION; GENE DELETION; GENE EXPRESSION; GLUCOSE TRANSPORT; GLYCOLYSIS; HEMATOPOIETIC STEM CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; ANIMAL; ANTAGONISTS AND INHIBITORS; BIOSYNTHESIS; GENE DOSAGE; GENETICS; KNOCKOUT MOUSE; METABOLISM; MITOCHONDRION; PHOSPHORYLATION;

ANIMALS; CHROMONES; DNA, MITOCHONDRIAL; ENZYME INHIBITORS; GENE DOSAGE; GLUCOSE; GLUTATHIONE; GLYCOLYSIS; HEMATOPOIETIC STEM CELLS; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; ISOENZYMES; L-LACTATE DEHYDROGENASE; LACTATE DEHYDROGENASES; MICE; MICE, KNOCKOUT; MITOCHONDRIA; MORPHOLINES; MULTIPROTEIN COMPLEXES; PHOSPHATIDYLINOSITOL 3-KINASES; PHOSPHORYLATION; PROTEIN-SERINE-THREONINE KINASES; PROTO-ONCOGENE PROTEINS C-AKT; REACTIVE OXYGEN SPECIES; REPRESSOR PROTEINS; TOR SERINE-THREONINE KINASES; TRANS-ACTIVATORS;

EID: 84891874604     PISSN: 15473287     EISSN: 15578534     Source Type: Journal    
DOI: 10.1089/scd.2013.0370     Document Type: Article

References (65)

1. Zhang J, CNiu, LYe, HHuang, XHe, WGTong, JRoss, JHaug, T Johnson, et al. (2003). Identification of the haematopoietic stem cell niche and control of the niche size. Nature 425:836-841.
2. Eliasson P and JI Jonsson. (2010). The hematopoietic stem cell niche: low in oxygen but a nice place to be. J Cell Physiol 222:17-22.
3. Simsek T, F Kocabas, J Zheng, RJ Deberardinis, AI Mahmoud, EN Olson, JW Schneider, CC Zhang and HA Sadek. (2010). The distinct metabolic profile of hematopoietic stem cells reflects their location in a hypoxic niche. Cell Stem Cell 7:380-390.
4. Basu S, HE Broxmeyer and G Hangoc. (2013). Peroxisome proliferator-activated-gamma coactivator-1alpha-mediated mitochondrial biogenesis is important for hematopoietic recovery in response to stress. Stem cells Dev 22:1678-1692.
5. Norddahl GL, CJ Pronk, M Wahlestedt, G Sten, JM Nygren, A Ugale, M Sigvardsson and D Bryder. (2011). Accumulating mitochondrial DNA mutations drive premature hema-topoietic aging phenotypes distinct from physiological stem cell aging. Cell Stem Cell 8:499-510.
6. Romero-Moya D, C Bueno, R Montes, O Navarro-Montero, FJ Iborra, LC Lopez, M Martin and P Menendez. (2013). Cord blood-derived CD34+ hematopoietic cells with low mitochondrial mass are enriched in hematopoietic re-populating stem cell function. Haematologica 98:1022-1029.
7. Ito K, A Hirao, F Arai, K Takubo, S Matsuoka, K Miyamoto, M Ohmura, K Naka, K Hosokawa, Y Ikeda and T Suda. (2006). Reactive oxygen species act through p38 MAPK to limit the lifespan of hematopoietic stem cells. Nat Med 12:446-451.
8. Jang YY and SJ Sharkis. (2007). A low level of reactive oxygen species selects for primitive hematopoietic stem cells that may reside in the low-oxygenic niche. Blood 110:3056-3063.
9. Takubo K, N Goda, W Yamada, H Iriuchishima, E Ikeda, Y Kubota, H Shima, RS Johnson, A Hirao, M Suematsu and T Suda. (2010). Regulation of the HIF-1alpha level is essential for hematopoietic stem cells. Cell Stem Cell 7:391-402.
10. Miharada K, G Karlsson, M Rehn, E Rorby, K Siva, J Cam-menga and S Karlsson. (2011). Cripto regulates hematopoi-etic stem cells as a hypoxic-niche-related factor through cell surface receptor GRP78. Cell Stem Cell 9:330-344.
11. Unnisa Z, JP Clark, J Roychoudhury, E Thomas, L Tessar-ollo, NG Copeland, NA Jenkins, HL Grimes and AR Kumar. (2012). Meis1 preserves hematopoietic stem cells in mice by limiting oxidative stress. Blood 120:4973-4981.
12. Kocabas F, J Zheng, S Thet, NG Copeland, NA Jenkins, RJ DeBerardinis, C Zhang and HA Sadek. (2012). Meis1 regulates the metabolic phenotype and oxidant defense of he-matopoietic stem cells. Blood 120:4963-4972.
13. Takubo K, G Nagamatsu, CI Kobayashi, A Nakamura-Ishizu, H Kobayashi, E Ikeda, N Goda, Y Rahimi, RS Johnson, et al. (2013). Regulation of glycolysis by pdk functions as a metabolic checkpoint for cell cycle quiescence in he-matopoietic stem cells. Cell Stem Cell 12:49-61.
14. Yilmaz OH, R Valdez, BK Theisen, W Guo, DO Ferguson, H Wu and SJ Morrison. (2006). Pten dependence distinguishes haematopoietic stem cells from leukaemia-initiating cells. Nature 441:475-482.
15. Zhang J, JC Grindley, T Yin, S Jayasinghe, XC He, JT Ross, JS Haug, D Rupp, KS Porter-Westpfahl, et al. (2006). PTEN maintains haematopoietic stem cells and acts in lineage choice and leukaemia prevention. Nature 441:518-522.
16. Chen C, Y Liu, R Liu, T Ikenoue, KL Guan and P Zheng. (2008). TSC-mTOR maintains quiescence and function of he-matopoietic stem cells by repressing mitochondrial biogenesis and reactive oxygen species. J Exp Med 205:2397-2408.
17. Gan B, E Sahin, S Jiang, A Sanchez-Aguilera, KL Scott, L Chin, DA Williams, DJ Kwiatkowski and RA DePinho. (2008). mTORC1-dependent and-independent regulation of stem cell renewal, differentiation, and mobilization. Proc Natl Acad Sci U S A 105:19384-19389.
18. Campbell TB, S Basu, G Hangoc, W Tao and HE Broxmeyer. (2009). Overexpression of Rheb2 enhances mouse hemato-poietic progenitor cell growth while impairing stem cell repopulation. Blood 114:3392-3401.
19. Huang J, M Nguyen-McCarty, EO Hexner, G Danet-Desnoyers and PS Klein. (2012). Maintenance of hemato-poietic stem cells through regulation of Wnt and mTOR pathways. Nat Med 18:1778-1785.
20. Kalaitzidis D, SM Sykes, Z Wang, N Punt, Y Tang, C Ragu, AU Sinha, SW Lane, AL Souza, et al. (2012). mTOR complex 1 plays critical roles in hematopoiesis and Pten-loss-evoked leukemogenesis. Cell Stem Cell 11:429-439.
21. Juntilla MM, VD Patil, M Calamito, RP Joshi, MJ Birnbaum and GA Koretzky. (2010). AKT1 and AKT2 maintain he-matopoietic stem cell function by regulating reactive oxygen species. Blood 115:4030-4038.
22. Kharas MG, R Okabe, JJ Ganis, M Gozo, T Khandan, M Paktinat, DG Gilliland and K Gritsman. (2010). Con-stitutively active AKT depletes hematopoietic stem cells and induces leukemia in mice. Blood 115:1406-1415.
23. Miyamoto K, KY Araki, K Naka, F Arai, K Takubo, S Yamazaki, S Matsuoka, T Miyamoto, K Ito, et al. (2007). Foxo3a is essential for maintenance of the hematopoietic stem cell pool. Cell Stem Cell 1:101-112.
24. Tothova Z, R Kollipara, BJ Huntly, BH Lee, DH Castrillon, DE Cullen, EP McDowell, S Lazo-Kallanian, IR Williams, et al. (2007). FoxOs are critical mediators of hematopoietic stem cell resistance to physiologic oxidative stress. Cell 128:325-339.
25. Gurumurthy S, SZ Xie, B Alagesan, J Kim, RZ Yusuf, B Saez, A Tzatsos, F Ozsolak, P Milos, et al. (2010). The Lkb1 metabolic sensor maintains haematopoietic stem cell survival. Nature 468:659-663.
26. Nakada D, TL Saunders and SJ Morrison. (2010). Lkb1 regulates cell cycle and energy metabolism in haematopoietic stem cells. Nature 468:653-658.
27. Gan B, J Hu, S Jiang, Y Liu, E Sahin, L Zhuang, E Fletcher-Sananikone, S Colla, YA Wang, L Chin and RA Depinho. (2010). Lkb1 regulates quiescence and metabolic homeosta-sis of haematopoietic stem cells. Nature 468:701-704.
28. Ito K, A Carracedo, D Weiss, F Arai, U Ala, DE Avigan, ZT Schafer, RM Evans, T Suda, CH Lee and PP Pandolfi. (2012). A PML-PPAR-delta pathway for fatty acid oxidation regulates hematopoietic stem cell maintenance. Nat Med 18: 1350-1358.
29. Yu WM, X Liu, J Shen, O Jovanovic, EE Pohl, SL Gerson, T Finkel, HE Broxmeyer and CK Qu. (2013). Metabolic regulation by the mitochondrial phosphatase PTPMT1 is required for hematopoietic stem cell differentiation. Cell Stem Cell 12:62-74.
30. Sun HB, YX Zhu, T Yin, G Sledge and YC Yang. (1998). MRG1, the product of a melanocyte-specific gene related gene, is a cytokine-inducible transcription factor with transformation activity. Proc Natl Acad Sci U S A 95:13555-13560.
31. Bhattacharya S, CL Michels, MK Leung, ZP Arany, AL Kung and DM Livingston. (1999). Functional role of p35srj, a novel p300/CBP binding protein, during transactivation by HIF-1. Genes Dev 13:64-75.
32. Bamforth SD, J Braganca, JJ Eloranta, JN Murdoch, FI Marques, KR Kranc, H Farza, DJ Henderson, HC Hurst and S Bhattacharya. (2001). Cardiac malformations, adrenal agenesis, neural crest defects and exencephaly in mice lacking Cited2, a new Tfap2 co-activator. Nat Genet 29:469-474.
33. Yin Z, J Haynie, X Yang, B Han, S Kiatchoosakun, J Restivo, S Yuan, NR Prabhakar, K Herrup, et al. (2002). The essential role of Cited2, a negative regulator for HIF-1alpha, in heart development and neurulation. Proc Natl Acad Sci U S A 99:10488-10493.
34. Bamforth SD, J Braganca, CR Farthing, JE Schneider, C Broadbent, AC Michell, K Clarke, S Neubauer, D Norris, et al. (2004). Cited2 controls left-right patterning and heart development through a Nodal-Pitx2c pathway. Nat Genet 36:1189-1196.
35. Weninger WJ, K Lopes Floro, MB Bennett, SL Withington, JI Preis, JP Barbera, TJ Mohun and SL Dunwoodie. (2005). Cited2 is required both for heart morphogenesis and establishment of the left-right axis in mouse development. Development 132:1337-1348.
36. Qu X, E Lam, YQ Doughman, Y Chen, YT Chou, M Lam, M Turakhia, SL Dunwoodie, M Watanabe, et al. (2007). Cited2, a coactivator of HNF4alpha, is essential for liver development. EMBO J 26:4445-4456.
37. Glenn DJ and RA Maurer. (1999). MRG1 binds to the LIM domain of Lhx2 and may function as a coactivator to stimulate glycoprotein hormone alpha-subunit gene expression. J Biol Chem 274:36159-36167.
38. Chen Y, P Haviernik, KD Bunting and YC Yang. (2007). Cited2 is required for normal hematopoiesis in the murine fetal liver. Blood 110:2889-2898.
39. Kranc KR, H Schepers, NP Rodrigues, S Bamforth, E Villadsen, H Ferry, T Bouriez-Jones, M Sigvardsson, S Bhattacharya, SE Jacobsen and T Enver. (2009). Cited2 is an essential regulator of adult hematopoietic stem cells. Cell Stem Cell 5:659-665.
40. Du J, Y Chen, Q Li, X Han, C Cheng, Z Wang, D Danielpour, SL Dunwoodie, KD Bunting and YC Yang. (2012). HIF-1alpha deletion partially rescues defects of hematopoietic stem cell quiescence caused by Cited2 deficiency. Blood 119:2789-2798.
41. Li Q, DL Ramirez-Bergeron, SL Dunwoodie and YC Yang. (2012). Cited2 controls pluripotency and cardiomyocyte differentiation of murine embryonic stem cells through Oct4. J Biol Chem 287:29088-29100.
42. Zhong JF, Y Zhao, S Sutton, A Su, Y Zhan, L Zhu, C Yan, T Gallaher, PB Johnston, WF Anderson and MP Cooke. (2005). Gene expression profile of murine long-term reconstituting vs. short-term reconstituting hematopoietic stem cells. Proc Natl Acad Sci U S A 102:2448-2453.
43. Pendergrass W, N Wolf and M Poot. (2004). Efficacy of MitoTracker Green and CMXrosamine to measure changes in mitochondrial membrane potentials in living cells and tissues. Cytometry A 61:162-169.
44. Rice GC, EA Bump, DC Shrieve, W Lee and M Kovacs. (1986). Quantitative analysis of cellular glutathione by flow cytometry utilizing monochlorobimane: some applications to radiation and drug resistance in vitro and in vivo. Cancer Res 46:6105-6110.
45. Hedley DW and S Chow. (1994). Evaluation of methods for measuring cellular glutathione content using flow cytome-try. Cytometry 15:349-358.
46. Yang L, T Kasumov, RS Kombu, SH Zhu, AV Cendrowski, F David, VE Anderson, JK Kelleher and H Brunengraber. (2008). Metabolomic and mass isotopomer analysis of liver gluconeogenesis and citric acid cycle: II. Heterogeneity of metabolite labeling pattern. J Biol Chem 283:21988-21996.
47. Ye F, H Lemieux, CL Hoppel, RW Hanson, P Hakimi, CM Croniger, M Puchowicz, VE Anderson, H Fujioka and E Stavnezer. (2011). Peroxisome proliferator-activated receptor gamma (PPARgamma) mediates a Ski oncogene-induced shift from glycolysis to oxidative energy metabolism. J Biol Chem 286:40013-40024.
48. Warr MR, M Binnewies, J Flach, D Reynaud, T Garg, R Malhotra, J Debnath and E Passegue. (2013). FOXO3A directs a protective autophagy program in haematopoietic stem cells. Nature 494:323-327.
49. Zhou W, M Choi, D Margineantu, L Margaretha, J Hesson, C Cavanaugh, CA Blau, MS Horwitz, D Hockenbery, C Ware and H Ruohola-Baker. (2012). HIF1alpha induced switch from bivalent to exclusively glycolytic metabolism during ESC-to-EpiSC/hESC transition. EMBO J 31:2103-2116.
50. Magnuson B, B Ekim and DC Fingar. (2012). Regulation and function of ribosomal protein S6 kinase (S6K) within mTOR signalling networks. Biochem J 441:1-21.
51. Furuyama T, K Kitayama, H Yamashita and N Mori. (2003). Forkhead transcription factor FOXO1 (FKHR)-dependent induction of PDK4 gene expression in skeletal muscle during energy deprivation. Biochem J 375:365-371.
52. Kim YI, FN Lee, WS Choi, S Lee and JH Youn. (2006). Insulin regulation of skeletal muscle PDK4 mRNA expression is impaired in acute insulin-resistant states. Diabetes 55:2311-2317.
53. Nahle Z, M Hsieh, T Pietka, CT Coburn, PA Grimaldi, MQ Zhang, D Das and NA Abumrad. (2008). CD36-dependent regulation of muscle FoxO1 and PDK4 in the PPAR delta/beta-mediated adaptation to metabolic stress. J Biol Chem 283:14317-14326.
54. Long YC, Z Cheng, KD Copps and MF White. (2011). Insulin receptor substrates Irs1 and Irs2 coordinate skeletal muscle growth and metabolism via the Akt and AMPK pathways. Mol Cell Biol 31:430-441.
55. Guo L, B Xie and Z Mao. (2012). Autophagy in premature senescent cells is activated via AMPK pathway. Int J Mol Sci 13:3563-3582.
56. Inoue S, S Noda, K Kashima, K Nakada, J Hayashi and H Miyoshi. (2010). Mitochondrial respiration defects modulate differentiation but not proliferation of hematopoietic stem and progenitor cells. FEBS Lett 584:3402-3409.
57. Apostolova N, LJ Gomez-Sucerquia, A Moran, A Alvarez, A Blas-Garcia and JV Esplugues. (2010). Enhanced oxidative stress and increased mitochondrial mass during efavirenz-induced apoptosis in human hepatic cells. Br J Pharmacol 160:2069-2084.
58. Geiger H, G de Haan and MC Florian. (2013). The ageing haematopoietic stem cell compartment. Nat Rev Immunol 13:376-389.
59. Todd LR, MN Damin, R Gomathinayagam, SR Horn, AR Means and U Sankar. (2010). Growth factor erv1-like modulates Drp1 to preserve mitochondrial dynamics and function in mouse embryonic stem cells. Mol Biol Cell 21:1225-1236.
60. Folmes CD, PP Dzeja, TJ Nelson and A Terzic. (2012). Metabolic plasticity in stem cell homeostasis and differentiation. Cell Stem Cell 11:596-606.
61. Yu X, N Shen, ML Zhang, FY Pan, C Wang, WP Jia, C Liu, Q Gao, X Gao, B Xue and CJ Li. (2011). Egr-1 decreases adipocyte insulin sensitivity by tilting PI3K/Akt and MAPK signal balance in mice. EMBO J 30:3754-3765.
62. Contractor T and CR Harris. (2012). p53 negatively regulates transcription of the pyruvate dehydrogenase kinase Pdk2. Cancer Res 72:560-567.
63. Bakker WJ, IS Harris and TW Mak. (2007). FOXO3a is activated inresponse tohypoxic stress and inhibits HIF1-induced apoptosis via regulation of CITED2. Mol Cell 28:941-953.
64. Lagadinou ED, A Sach, K Callahan, RM Rossi, SJ Neering, M Minhajuddin, JM Ashton, S Pei, V Grose, et al. (2013). BCL-2 inhibition targets oxidative phosphorylation and selectively eradicates quiescent human leukemia stem cells. Cell Stem Cell 12:329-341.
65. Haferlach T, A Kohlmann, L Wieczorek, G Basso, GT Kronnie, MC Bene, J De Vos, JM Hernandez, WK Hofmann, et al. (2010). Clinical utility of microarray-based gene expression profiling in the diagnosis and subclassification of leukemia: report from the International Microarray Innovations in Leukemia Study Group. J Clin Oncol 28:2529-2537.